Chronic Allograft Enteropathy Treated with Vedolizumab: A Case Report
To our knowledge, this case represents the first use of vedolizumab in such a circumstance and provides evidence of its usefulness as a rescue therapy for chronic intestinal rejection to, at least, extend graft survival.
Authors
- Klaas Nico Faber (ORCID: https://orcid.org/0000-0001-8893-3312)
- Tjasso Blokzijl (ORCID: https://orcid.org/0000-0003-3351-7092)
- Gürsah Kats‐Ugurlu (ORCID: https://orcid.org/0000-0002-3006-5978)
- Gerard D. H. Dijkstra (ORCID: https://orcid.org/0000-0003-4563-7462)
- Jan Willem Haveman (ORCID: https://orcid.org/0000-0002-5272-7565)
- Guido Trentadue (ORCID: https://orcid.org/0000-0001-8770-8375)
Institutions
- University Medical Center Groningen (NL)
- University of Groningen (NL)
Publication Details
- Journal
- Transplantation Proceedings
- Published
- 2024-12-04
- DOI
- https://doi.org/10.1016/j.transproceed.2024.11.021
- Citations
- 1
- Primary Topic
- Inflammatory Myopathies and Dermatomyositis
- Type
- article
- Field-Weighted Citation Impact
- 0.39